This trial is testing whether a new treatment can help kidney transplant patients with high levels of antibodies to get a kidney from a deceased donor.
1 Primary · 1 Secondary · Reporting Duration: From signing informed consent to 12 months
Experimental Treatment
64 Total Participants · 1 Treatment Group
Primary Treatment: Imlifidase · No Placebo Group · Phase 3
Age 18 - 70 · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: